Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

Egyptian Rheumatology and Rehabilitation

Table 5 Correlation analysis of HAQ, BASFI, and NHP by age group

Group	Scale	HAQ	BASFI	MARS
18–64 years (group 1)	HAQ			− 0.592^**
	BASFI			− 0.670^**
	NHP pain	0.750^**	0.954^**	− 0.750^**
	NHP emotional reaction	0.462^**	0.663^**	− 0.602^**
	NHP sleep	0.410^**	0.643^**	− 0.599^**
	NHP social isolation	0.396^**	0.442^**	− 0.520^**
	NHP physical activity	0.633^**	0.715^**	− 0.647^**
	NHP energy	0.553^**	0.561^**	− 0.634^**
	MARS	− 0.592^**	− 0.670^**
≥ 65 years (group 2)	HAQ			− 0.622^**
	BASFI			− 0.643
	NHP pain	0.726^**	0.863^*	− 0.916^**
	NHP emotional reaction	0.648^**	0.756^*	− 0.832^**
	NHP sleep	0.619^**	0.863^*	− 0.705^**
	NHP social isolation	0.565^**	− 0.158	− 0.591^**
	NHP physical activity	0.658^**	0.973^**	− 0.827^**
	NHP energy	0.715^**	0.422	− 0.765^**
	MARS	− 0.622^**	− 0.643

*P ≤ 0.05; **P < 0.001 HAQ Health Assessment Questionnaire, BASFI Bath Ankylosing Spondylitis Functional Index, MARS Medication Adherence Rating Scale
P ≤ 0.05 is considered significant